Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Carbon–phosphorus stapled Au( i ) anticancer agents via bisphosphine induced reductive elimination

Dalton Transactions(2024)10.1039/d4dt01929fSource: DataRank Database

Carbon–phosphorus stapled Au( i ) anticancer agents via bisphosphine induced reductive elimination is a research paper published in Dalton Transactions (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.84)OA: hybridTopics (50)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Oluwatosin A. Obisesan ORCID,Sean Parkin ORCID,Samuel G. Awuah ORCID,Sean T. Gilpatrick ORCID

Live enrichment

PubMed:39161271 OpenAlex:https://openalex.org/W4401577110

National Cancer Institute

Grant: R01CA258421-01

National Science Foundation

Grant: CHE-997738

National Science Foundation

Grant: CHE-1625732

National Institute of General Medical Sciences

Grant: P20GM130456

National Institutes of Health

Grant: 5P20GM130456-03

Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation

National Institutes of Health

Grant: 3P30CA177558-01S1

CTRP Supplement

National Institutes of Health

Grant: 5R01CA258421-05

Gold-derived therapeutic compounds for disease application

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2025

2026

hybridLicense: cc-by-nc

journalhttps://pubs.rsc.org/en/content/articlepdf/2024/dt/d4dt01929f

publisherhttps://pubs.rsc.org/en/content/articlepdf/2024/dt/d4dt01929f

publisherhttp://pubs.rsc.org/en/content/articlepdf/2024/DT/D4DT01929F

journalhttps://doi.org/10.1039/d4dt01929f

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39161271

Fields of Study

Asymmetric Hydrogenation and CatalysisInnovative Microfluidic and Catalytic Techniques InnovationChemical Synthesis and Analysis0301 basic medicine01 natural sciences0104 chemical sciences03 medical and health sciences

MeSH Terms

Antineoplastic AgentsCarbonDrug Screening Assays, AntitumorGoldHumansModels, MolecularOxidation-ReductionPhosphinesPhosphorusMolecular StructureApoptosisReactive Oxygen SpeciesCrystallography, X-RayCell Line, TumorCell ProliferationMembrane Potential, MitochondrialCoordination Complexes

Keywords

ChemistryPhosphorusCombinatorial chemistryCarbon fibersReductive eliminationStereochemistryMedicinal chemistryOrganic chemistryMaterials scienceCatalysisModels, MolecularMembrane Potential, MitochondrialMolecular StructurePhosphinesAntineoplastic AgentsApoptosisCrystallography, X-RayCarbonCoordination ComplexesCell Line, TumorHumansGoldDrug Screening Assays, AntitumorReactive Oxygen SpeciesOxidation-ReductionCell Proliferation

Sustainable Development Goals

SDG 0: Clean water and sanitation